thefuturemarkets.com
Roche Holding AG to buy Spark Therapeutics in $4.3 billion deal
Roche to buy gene therapy specialist Spark in $4.3 billion deal Roche already sells Hemlibra, a drug against haemophilia A that helps stop bleeding in patients with the life-threatening genetic dis…